About Therapeutic Foresight
Expertise & Innovation
Engage with us to harness our specialized expertise in biotech investment, innovation acceleration, API outsourcing support, and peptide services. Our comprehensive strategic consulting and scientific evaluation services cover a broad spectrum, from peptide chemistry to nanotechnology and gene delivery vectorization, fostering technological advancements in the life sciences.
Anthony CLOUET, PhD, Executive MBA, Safety Officer combines cutting-edge scientific expertise with strategic vision and robust management experience.
• Strategic Leadership: Managed complex R&D programs from concept to commercialization batches, fostering innovation in regulated environments. Led multidisciplinary teams in peptide R&D and advanced therapies (gene delivery, focused ultrasounds therapy).
• Business Development: Expert in biotech investment strategies and 10+ scientific due diligence assignments, successfully securing significant funding ($65M Serie A). Pitching to VCs, Negotiates and structures strategic research collaborations.
• Operational Excellence: Managed pharmaceutical operations, ensuring regulatory compliance (GMP, FDA, EMA, NMPA), and implemented robust HSE systems (ISO 14001/45001).
• Cross-Functional Skills: Possesses strong analytical, problem-solving, and strategic communication skills, building effective relationships with stakeholders and clients.
Anthony's blend of scientific depth, strategic acumen, and leadership makes him a pivotal force in advancing therapeutic innovations and driving sustainable growth in the life sciences sector.
Experience
- 20+ years in pharmaceutical R&D and development
- 10+ scientific due diligences conducted
- $65M in Series A funding secured (support/advisory)
- 7 patents · 6 publications
Engage With Us
Your Scientific Strategic Ally
Trust our expertise in life sciences to drive your scientific and business objectives forward.